These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 10122036)
21. Challenges of a P & T Committee in a community teaching hospital. Cooke DH; Kessler J Hosp Formul; 1990 Aug; 25(8):878-82, 886. PubMed ID: 10105706 [TBL] [Abstract][Full Text] [Related]
22. P & T Committee roundtable discussion: Eastern region. Part I. Fine DJ; Guild RT; Kleinmann K; Kupersmith J Hosp Formul; 1984 Jun; 19(6):469-72, 475-6. PubMed ID: 10266565 [TBL] [Abstract][Full Text] [Related]
23. How to use structured decision making in developing therapeutic, cost-effective formulary systems. Crane VS Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135 [TBL] [Abstract][Full Text] [Related]
24. How to crack the $2 billion hospital market for pharmaceuticals. Zellmer WA Med Mark Media; 1981 May; 16(5):16, 24. PubMed ID: 10251527 [No Abstract] [Full Text] [Related]
25. P & T Committee roundtable discussion: Great Lakes region. Part II. McQuone M; Salberg DJ; Weintraub M Hosp Formul; 1984 Feb; 19(2):129-32, 136-8, 147-8. PubMed ID: 10264742 [TBL] [Abstract][Full Text] [Related]
26. Therapeutic substitution and the hospital formulary system. Doering PL; McCormick WC; Klapp DL; Russell WL Am J Hosp Pharm; 1981 Dec; 38(12):1949-51. PubMed ID: 7325179 [TBL] [Abstract][Full Text] [Related]
27. The foremost problems associated with formulary management. Davis NM Hosp Pharm; 1983 Mar; 18(3):131, 134-5. PubMed ID: 10260204 [No Abstract] [Full Text] [Related]
28. A survey of selective administration procedures in formulary maintenance. Quigley MA; Brown WM Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001 [TBL] [Abstract][Full Text] [Related]
29. The role of the Pharmacy and Therapeutics Committee in materiel management. Moss RL; Bowman JD; Smith W Hosp Mater Manage Q; 1990 Feb; 11(3):61-5. PubMed ID: 10103649 [No Abstract] [Full Text] [Related]
30. Developing an effective P & T Committee, Part 2. Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830 [TBL] [Abstract][Full Text] [Related]
31. Implementing an automatic fluoroquinolone therapeutic interchange program in a community hospital. Mioduch HJ Hosp Formul; 1992 Sep; 27(9):943-4, 947. PubMed ID: 10128743 [TBL] [Abstract][Full Text] [Related]
33. What should your formulary look like? Lanser EG Healthc Exec; 2002; 17(1):52. PubMed ID: 11822245 [No Abstract] [Full Text] [Related]
34. P & T Committee formulary requests: criteria for admission. Weintraub M; Guttmacher L Hosp Formul; 1984 Oct; 19(10):975-7, 980. PubMed ID: 10268315 [TBL] [Abstract][Full Text] [Related]
35. P & T committees and the hospital formulary. Evans PJ; Standish RC; Bell JE Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367 [No Abstract] [Full Text] [Related]
36. The formulary system: product of the teaching hospital. Francke DE Hospitals; 1967 Nov; 41(22):110 passim. PubMed ID: 6062395 [No Abstract] [Full Text] [Related]
37. Prospective reimbursement and DRGs: implications for formulary management. Enright SM Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246 [No Abstract] [Full Text] [Related]